The group has received a grant from the Convergent Science Cancer Consortium involving researchers at MD Anderson Cancer Center, Vanderbilt University, and UH. Our pilot project is focused on the role of efferocytosis in cellular therapies. We are excited to be part of this interdisciplinary team bring innovative approaches to next generation cell therapies.